| Net Cash Provided by (Used in) Operating Activities |
$828,000 |
USD |
-156% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$5,480,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$1,328,000 |
USD |
33% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
200,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
93,523,028 |
shares |
|
Q3 2024 |
Q3 2024 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$3,263,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
$56,510,000 |
USD |
72% |
Q4 2024 |
FY 2024 |
| Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
0% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Gross |
$62,740,000 |
USD |
23% |
Q4 2024 |
FY 2024 |
| Payments to Acquire Property, Plant, and Equipment |
$2,182,000 |
USD |
9.4% |
Q1 2025 |
Q1 2025 |
| Property, Plant and Equipment, Gross |
$316,644,000 |
USD |
4.7% |
Q3 2025 |
Q3 2025 |
| Additional Paid in Capital |
$138,392,000 |
USD |
21% |
Q3 2025 |
Q3 2025 |
| Depreciation, Depletion and Amortization |
$2,918,000 |
USD |
-36% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$6,230,000 |
USD |
-66% |
Q4 2024 |
FY 2024 |
| Share-based Payment Arrangement, Expense |
$1,228,000 |
USD |
49% |
Q3 2025 |
Q3 2025 |